A Two-stage Prospective Observational Cohort Study in Scleroderma Patients to Evaluate Screening Tests and the Incidence of Pulmonary Arterial Hypertension and Pulmonary Hypertension

Trial Information

Generic NameN/AProduct NameN/ATherapeutic AreaCardiovascular SystemProduct ClassAntihypertensivesCondition StudiedScleroderma, SystemicChemical SubgroupsN/APharmacological SubgroupsN/A
Sponsor Protocol NumberAC-052-510Enrollment490Data PartnerJohnson & Johnson% Female81.0%Mean/Median Age (Years)57.1% White90.5%

Supporting Documentation

  • Collected Datasets Available
  • Data Definition Specification Available
  • Protocol with Amendments Available
  • Statistical Analysis Plan Available
  • Clinical Study Report Available
Additional Information

Please note: this is an observational study.

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.